-
Canagliflozin as an mTOR Assay Boundary Probe
2026-08-19
Canagliflozin hemihydrate is best known for renal glucose reabsorption inhibition, but a 2025 yeast study gives it a second research value: a negative-control boundary probe for mTOR inhibitor discovery. This article explains how to use that finding to design, interpret, and troubleshoot glucose metabolism research assays.
-
Cell lysis buffer for WB and IP in CAF Studies
2026-08-18
Translate CAF-driven chemoresistance biology into cleaner Western blot, co-IP, and signaling workflows with a non-denaturing extraction strategy. This guide shows how to use inhibitor-protected lysates to examine the ANGPTL4–IQGAP1 axis while preserving protein abundance, phosphorylation, and native complexes.
-
Ceftolozane Sulfate: From Target to Translation
2026-08-18
A translational framework for using Ceftolozane sulfate in mechanism-driven susceptibility testing, PK/PD studies, infection models, and resistance-aware development programs.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-08-17
A 2025 study developed a high-throughput imaging platform to track nucleic acid-loaded lipid nanoparticles (LNPs) through intracellular compartments. Its findings indicate that excess cholesterol promotes aggregation of LNP-containing peripheral early endosomes, restricting endolysosomal progression and reducing access to compartments associated with cargo release.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit
2026-08-17
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit is a Cy5 RNA labeling kit for tunable fluorescent RNA probe synthesis by T7-driven in vitro transcription. Its Cy5-UTP substitution strategy supports probe preparation for in situ hybridization and Northern blot hybridization while requiring empirical optimization of labeling versus transcription yield.
-
IWP-L6: Practical Porcupine Inhibition Workflows
2026-08-16
IWP-L6 provides upstream control of Wnt ligand maturation, making it useful for separating endogenous Wnt production from downstream pathway effects. This guide translates its sub-nanomolar potency into practical workflows for signaling, metabolism, organ culture, and regeneration assays.
-
Protoporphyrin IX in Ferroptosis Workflows
2026-08-15
Use Protoporphyrin IX as a carefully controlled probe of heme formation, iron handling, and light-triggered oxidative injury. This workflow connects photodynamic assays with the METTL16–SENP3–LTF ferroptosis axis while separating direct evidence from practical assay extensions.
-
Anlotinib and VEGFR2-Driven Tumor Angiogenesis
2026-08-14
The 2018 Cancer Science study established anlotinib as a highly potent, relatively selective VEGFR2 inhibitor with activity spanning kinase assays, endothelial models, aortic explants, and tumor-bearing mice. Its layered design links endothelial signaling blockade to reduced angiogenesis and stronger oral antitumor activity than sunitinib in several preclinical settings, while also clarifying that direct tumor-cell inhibition requires substantially higher concentrations.
-
GW 6471: Reframing PPARα in Translational Research
2026-08-14
GW 6471 provides a mechanistically defined way to interrogate PPARα-dependent transcription, connecting receptor biology with lipid homeostasis, hepatotoxicity, and metabolic disease research. This article translates findings from a PFHxS-exposed zebrafish model into a disciplined pharmacology strategy, while distinguishing evidence-supported conclusions from future translational hypotheses.
-
ERADECs for Targeted Membrane Protein Degradation
2026-08-13
Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule targeted protein degradation platform that redirects transmembrane proteins to ER-associated degradation through the E3 ligase SYVN1. Desonide-based ERADECs achieved highly effective PD-L1 depletion, sub-nanomolar activity, and stronger in vivo tumor suppression than a clinically used PD-L1 antibody, while also supporting degradation of mutant HTT.
-
Niclosamide Workflows for STAT3 Cancer Research
2026-08-13
Build more informative cancer assays with Niclosamide by pairing STAT3 Tyr-705 measurements with viability, apoptosis, and cell-cycle endpoints. This guide translates concentration–time design principles from a comparative molluscicidal study into practical, clearly bounded workflows for prostate cancer and acute myelogenous leukemia model research.
-
EdU Cy5 Imaging for Neurodevelopmental Translation
2026-08-12
A translational framework for using EdU/Cy5 detection to connect S-phase DNA synthesis with neurodevelopmental mechanisms, assay quality, and preclinical decision-making.
-
Hereditary Angioedema Treatment: Mechanisms and Evidence
2026-08-12
This 2021 review organizes treatment of C1-inhibitor deficiency hereditary angioedema around acute attack management, preprocedure prophylaxis, and long-term prevention. Its main contribution is a mechanism-based account linking therapeutic advances to inhibition of the kallikrein–kinin system, while distinguishing established options from drugs still under development.
-
CA800-PR Targets Progesterone Signaling in HR+ Breast Cancer
2026-08-11
The reference study introduces CA800-PR, a hydrophilic heptamethine cyanine dye designed to combine tumor targeting, near-infrared imaging, and treatment of hormone receptor-positive breast cancer. In MCF-7 cell and xenograft models, the dye was associated with Golgi fragmentation, selective suppression of progesterone receptor expression, apoptosis, cytokine production, and enrichment of antitumor M1-type macrophages.
-
0.4% Trypan Blue Solution: Technical Guide
2026-08-11
0.4% Trypan Blue Solution provides a direct cell viability measurement by distinguishing non-blue viable cells from blue dead or membrane-damaged cells during research cell counting and cytotoxicity workflows. It is intended for scientific research only, not for diagnostic or medical use, and should be interpreted as a membrane-integrity assay rather than a pathway-specific death assay.